Navigation Links
Supplemental Oxygen Company Offers Steps to Improve COPD Patients' Lives
Date:8/19/2010

AUSTIN, Texas, Aug. 19 /PRNewswire/ -- What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.

Although such symptoms can begin as a mild annoyance, they can get worse with time. Eventually patients find themselves short of breath doing simple activities, like preparing a meal or getting dressed.

But there is reason for hope.

Once diagnosed with COPD, often also referred to as emphysema or chronic bronchitis, there are multiple treatment options and ways to manage the disease and improve one's quality of life.  

The COPD Foundation offers multiple tips for better breathing and managing the often debilitating disease.

  • Avoid triggers and exposure to pollutants - Stay away from things such as dust, strong fumes and cigarette smoke that could irritate your lungs. Also, stay indoors as much as possible when the outside air quality is poor. It is best to avoid crowds during flu season and it is a good idea to get an annual flu shot.
  • Try various breathing techniques such as:
  • Pursed-lip breathing - Inhale through your nose for four seconds. Then exhale through your mouth for six-to-eight seconds, with your lips almost closed.
  • Belly breathing - Breathing with your diaphragm makes more space for your lungs to take in air.
  • Bend forward - Bending at the waist helps the diaphragm move more easily, allowing more air to fill the lungs. You can sit or stand with this technique, as long as you lean slightly forward from the waist, keeping your back straight.
  • Consider a change in lifestyle
  • Eat well - It is especially important for a COPD sufferer to eat a well balanced diet. Emphysema patients tend to be very thin and should include plenty of nutrients and supplements in their diet. Bronchitis patients on the other hand may be overweight, which places extra burden on the lungs.
  • Quit smoking - It is never too late to kick the habit.

  • Changing lifestyle habits, avoiding triggers and practicing breathing techniques may only go so far. A physician may recommend oxygen therapy for patients with severe COPD. To some, oxygen therapy is viewed as a death sentence because they think of the heavy oxygen tanks that must be wheeled behind them. Oxygen therapy patients no longer need to view their supplemental oxygen prescription as a homebound sentence. Bulky oxygen tanks and carts may one day be obsolete thanks to the LifeChoice® Oxygen Concentrator, a new home medical product for supplemental oxygen users.

    "It is lighter and more compact than anything that I have seen," Dr. Robert Emerson, Chief of Pulmonary Medicine at the Austin Diagnostic Clinic, said.  "As a pulmonary specialist who sees many COPD patients weekly, I notice a tremendous difference in those who use a portable oxygen concentrator, such as the LifeChoice®, versus those who lug around heavy tanks."

    LifeChoice by Inova Labs is the smallest stationary and portable oxygen concentrator available, weighing less than five pounds. It offers true mobility for its users and allows them the freedom to again experience simple joys such as walking outside without cumbersome equipment.

    "We have had numerous patients send us personal thank you notes expressing their deep gratitude for inventing something that has transformed how they live with COPD," David Shockley Jr., Inova Labs president, said.

    The LifeChoice, with the patent pending Sleep Mode technology, is the only portable concentrator system designed with endless oxygen pulse for round-the-clock use.

    For additional information, visit http://lifechoiceoxygen.com or call the customer care center at 1-877-490-3339.

    About Inova LabsInova Labs, which was founded in 2002, is a medical device development, manufacturer and worldwide distribution company primarily focused on direct patient care products. Inova Labs invented, developed, owns, manufactures and is the exclusive worldwide master distributor of the LifeChoice portable oxygen concentrator. The LifeChoice is revolutionizing oxygen therapy and patient freedom. Inova Labs is an FDA-registered company and fully ISO 13485 compliant utilizing state-of-the-art manufacturing systems. Inova Labs, Inc., along with its manufacturing factory, is headquartered, in Austin, Texas, where the LifeChoice is made.Contact: Lindsey Elbom or Meredith Michelson, 512-472-9599lelbom@echristianpr.com or mmichelson@echristianpr.comElizabeth Christian & Associates Public RelationsAvailable Topic Expert(s): For information on the listed expert(s), click appropriate link.

    David Shockley

    https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=96433


    '/>"/>
    SOURCE Inova Labs
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
    2. ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM)
    3. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
    4. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
    5. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
    6. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
    7. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
    8. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
    9. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
    10. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
    11. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/19/2016)... , May 19, 2016 ... World Congestive Heart Failure (CHF) Treatment Devices Market - ... CHF treatment devices market would reach $14.8 billion by ... 2022. Implantable cardioverter-defibrillator (ICDs) segment is expected to dominate ... period. North America is projected ...
    (Date:5/19/2016)... 19, 2016 Research ... "Global In-Vitro Diagnostics (IVD) Market Size, Market ... Key Players, Competitive Strategies and Forecasts, 2012 ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... research report forecasts on In-Vitro Diagnostics (IVD) ...
    (Date:5/19/2016)...  IBM,s (NYSE:   IBM )  World Community Grid ... drug candidates to cure Zika, a fast spreading virus ... public health emergency. IBM and a global ... or Android device to join the #OpenZika project. Volunteers ... help; they simply  run an app   on ...
    Breaking Medicine Technology:
    (Date:5/23/2016)... CA (PRWEB) , ... May 23, 2016 , ... Researchers ... is so routine. A fresh look at this technique may yield big benefits. ... reproducibility of experiments in a cell culture laboratory—and lessen the risk of ...
    (Date:5/23/2016)... New York, NY (PRWEB) , ... May 23, 2016 , ... ... revolutionary, sport-injury preventative testing program for athletes. This is the first time this type ... South California, is being made available to the public in New York. , With ...
    (Date:5/23/2016)... ... 23, 2016 , ... ComplianceOnline, the leading governance, risk and compliance advisory network ... September 15 and 16, 2016 in San Diego, CA. The two day summit ... be one of the largest gatherings of medical device companies, suppliers, professionals and experts ...
    (Date:5/23/2016)... ... May 23, 2016 , ... ... today that nominations will be accepted May 23, 2016 through August 5, ... include the Information Security Executive® of the Year, which recognizes executives who ...
    (Date:5/23/2016)... ... 23, 2016 , ... Hadley Institute for the Blind and ... blind or visually impaired, announces the election of Julie S. Tye as its ... Board of Trustees retained Morris & Berger, a firm specializing in non-profit executive ...
    Breaking Medicine News(10 mins):